Skip to main content
OpenTrials

Clinical trial condition

Advanced or Metastatic Non-small Cell Lung Cancer

Explore clinical trials studying Advanced or Metastatic Non-small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

9 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Advanced or Metastatic Non-small Cell Lung Cancer trial results

Recruiting

A Platform Study in Non-Small Cell Lung Cancer (NSCLC)

NCT06996782

Conditions
Advanced or Metastatic Non-small Cell Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +8 more
Locations
  • Research Site Phoenix, Arizona, United States
  • Research Site Santa Rosa, California, United States
  • Research Site Jacksonville, Florida, United States
  • Research Site Baltimore, Maryland, United States
View all 103 locations
View Trial Details
Completed

Study of Carboplatin/Paclitaxel in Combination With ABT-869 in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

NCT00716534

Conditions
Advanced or Metastatic Non-small Cell Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +8 more
Locations
  • Site Reference ID/Investigator# 15850 Chandler, Arizona, United States
  • Site Reference ID/Investigator# 15846 Peoria, Arizona, United States
  • Site Reference ID/Investigator# 15841 Miami, Florida, United States
  • Site Reference ID/Investigator# 7179 Atlanta, Georgia, United States
View all 37 locations
View Trial Details
Active, Not Recruiting

A Phase III Study of Ceralasertib Plus Durvalumab Versus Docetaxel in Patients With Non Small Cell Lung Cancer (NSCLC) Whose Disease Progressed On or After Prior Anti PD (L)1 Therapy And Platinum Based Chemotherapy

NCT05450692

Conditions
Advanced or Metastatic Non-small Cell Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +8 more
Locations
  • Research Site Mobile, Alabama, United States
  • Research Site Chandler, Arizona, United States
  • Research Site Los Alamitos, California, United States
  • Research Site Los Angeles, California, United States
View all 191 locations
View Trial Details
Active, Not Recruiting

A Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab in Participants With Epidermal Growth Factor Receptor (EGFR)-Mutated Advanced or Metastatic Non-small Cell Lung Cancer

NCT05388669

Conditions
Advanced or Metastatic Non-small Cell Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +8 more
Locations
  • City of Hope Duarte Duarte, California, United States
  • City of Hope Orange County Lennar Foundation Cancer Center Irvine, California, United States
  • City of Hope Long Beach Elm Long Beach, California, United States
  • National Jewish Health Denver, Colorado, United States
View all 187 locations
View Trial Details

Related conditions